Spleen cells from random-bred chickens bearing Rous sarcomas were commonly more reactive against the neoplastic target cells'in autochthonous than in allogeneic interactions in vitro. This difference was observed both in cytotoxic assays (hCr release from labeled target cells) and in an immunoadherence test measuring attachment of $"Cr-labeled splenocytes to Rous sarcoma cells. Specific splenocyte reactivity was not observed with normal embryonic chicken fibroblasts, 3T3 cells, or embryonic mouse C3H fibro'blasts. The immunoadherence technique required only 2 hr to perform, and revealed a more consistent superiority of autochthonous recognition of Rous sarcoma cells than the cytotoxicity assay. Experiments in which both procedures were used simultaneously with identical cell populations yielded similar resiilts, indicating that splenocyte adherence may be a precursor of and/or concomitant to target cell damage and that individual-specific tumor antigencity may play a part in cellular immunity against Rouis sarcomas.
The host-tumor relationship of chickens bearing Rous sarcomas has a number of advantages as a model pertinent to neoplasia in man. The tumor host is an outbred, nonlaboratory adapted animal, and the virus that induces the neoplastic transformation is one of a family of agents whose members are oncogenic in nature as well as in the laboratory, and active in a broad range of species in addition to the chicken (1) . Cellular and humoral immunity in this system is well established both in vito and in vitro (2, 3) , and the chicken lends itself uniquely to the separation of lymphoid cell populations of diverse origin, and thereby to a differential definition of immunological capacity (4) .
The purpose of the present investigation was to compare splenocyte-target cell interaction in both autochthonous and allogeneic confrontations between Rous sarcoma cells and effector cells, by use of splenocytes sensitized during the course of the host's experience with a primary, actively growing tumor-a situation reflecting the only type of interaction that can be studied in man.
This interaction was evaluated by a newly developed quantitative immunoadherence test, and by the cytotoxicity assay based on the liberation of labeled chromium from target cells.
The findings presented here show that splenocytes from primary Rous sarcoma hosts have a consistently superior Abbreviations: RS, Rous sarcoma; standard medium, medium 199 supplemented with serum, tryptose phosphate, and antibiotics; insulin medium, standard medium in which serum is replaced by insulin.
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competence for recognizing the autochthonous than allogeneic neoplastic targets, and a frequently superior ability to inflict injury on the autochthonous tumor cells. If preferential autochthonous recognition will prove to be a general phenomenon in tumor immunology, resort to autochthonous target cells for the assessment of resistance in animals and man in vitro will have to be considered a condition for accuracy and relevance. Proc. Nat. Acad. Sci. U$A 7i (i974) allogeneic clustering was always appreciably more marked than that seen with normal splenocytes. In order to quantitate this phenomenon, we labeled splenocytes with 5"Cr and the radioactivity of the adherent spleen cell population was determined. Fig. 1 shows the results of a typical experiment. Splenocyte adherence increased with time during all three types of interaction, before leveling off after 2-3 hr. It is also evident that autochthonous splenocyte reactivity was more pronounced than allogeneic reactivity, which in turn was better than that evinced by the control spleen cells. These differences were observed in every one of 16 consecutive experiments, and were cumulatively significant (P < 0.0005; one-tailed paired t test).
MATERIALS AND METHODS

Virus
In order to rule out the possibility that the greater adherence effected by autochthonous splenocytes arose as a consequence of surgical removal of part of the tumor 3 days before the effector cells were harvested, "criss-cross" experiments were performed, in which target cells were prepared from each of two donors on which we had performed operations. When the splenocytes of each donor were tested against both the authochthonous and allogeneic tumor cells in comparison with splenocytes from a third tumor-bearing animal on which we had not operated, we found that the highest levels of adherence again occurred in the autochthonous interactions. The results of one such experiment are shown in Fig.  2 . Two further criss-cross experiments provided identical findings.
To test the specificity of the adherence phenomenon, we incubated splenocytes from both normal and tumor-bearing donors with different types of normal cells in culture. Fig. 3 shows that, with respect to normal chicken embryo cells, cells of the 3T3 line, and C3H mouse fibroblasts, the adherence capacities of both types of splenocyte populations did not differ.
Cytotoxic Effect of Normal and Sensitized Splenocytes on RS Cells. Normal spleen cells did not effect a release of 51Cr above spontaneous release levels under the conditions of these experiments.
The results of eight consecutive trials analyzing the cytotoxic capacity of sensitized splenocytes against autochthonous and allogeneic target cells are summarized in Table 1 . Interaction with sensitized autochthonous splenocytes caused significant cell damage in 9 of 11 cases, whereas such effect was seen only in 9 of 17 cases for sensitized allogeneic splenocytes. The autochthonous interaction was significantly more damaging than the allogeneic one in 6 of the 11 cases, whereas in no instance was the reverse true. The cytotoxic activity of sensitized splenocytes against both the autochthonous and the allogeneic target cells was first significant after 6 hr of interaction.
In order to ascertain the specificity of RS target cell killing by splenocytes from tumor-bearing donors, 61Cr-release experiments were also performed with monolayers of normal chicken embryo cells. ential reactivity of sensitized splenocytes against autochthonous target cells was again evident in both systems. It is seen that the sensitized splenocytes showing the greatest immunoadherence activity were generally also the most potent in the cytotoxicity tests. It thus appears that adherence of splenocytes to RS cells, which takes place within 2 hours after contact, may be concomitant to, and possibly a forerunner of, severe target cell injury, as indicated by specific 51Cr release. t Probability of significant difference from allogeneic splenocytes.
of allogeneic Rous tumor cells. As indicated by the adherence of splenocytes to the neoplastic target cells, and by splenocyte-mediated cytotoxicity, a greater degree of reactivity was frequently observed in autochthonous interactions. The superiority of autochthonous recognition and cytotoxic capacity was highly significant despite the considerable variation from host to host in the extent of splenocyte immune adherence and cytotoxic action against both autochthonous and allogeneic targets. These observations confirm previous reports of cellular immune manifestations in chickens against Rous sarcomas (3), and they point to the existence of a hostspecific dimension of immunological ability. Gelderblom et al. (9) and Kurth and Bauer (10) demonstrated that at least two distinct cell-surface antigens are associated with chicken cells transformed by Rous sarcoma virus: a group-specific antigen of avian leukosis virus expressed only on the cell surface of the transformed cell, and a virus subgroup-specific antigen located on the envelope of virus particles budding from the plasma membrane. Our findings of an additional individual-specific aspect of host reactivity to RS cells could reflect either qualitative or quantitative variations from tumor to tumor in the expression of one or another of these Rous-associated antigens, or the occurrence of still other antigens, in some way unique for each tumor, and perhaps not directly associated with the oncogenic agent. Other workers have also reported the appearance of protective antigens specific to individual tumors, superimposed on the crossreactive antigens associated with a common oncogenic virus (11) .
Hayami et al. (12) , working with Rous sarcomas in quails, did not detect differences in cellular immunity directed against autochthonous as compared with allogeneic target cells. Moreover, these workers could detect lymphocytemediated cytotoxicity only with effector cells from birds with regressing tumors, whereas we found such activity in splenocytes from chickens with progressively developing sarcomas. These differences in results could be due in part to the use by Hayami et al. of birds from a small, closed breeding colony, i.e., a population of tumor hosts with a narrowed range of of variant individual characteristics; in addition, the quails were challenged simultaneously with two tumors, a circumstance that could lead more readily to a state of specific immunological unresponsiveness.
The adherence and clustering of sensitized lymphoid cells on allogeneic normal target cells have been extensively studied (13, 14) and have also been described for a number of tumor target cell systems (15) (16) (17) (18) 
